These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 655662

  • 1. Dopamine binding following prolonged haloperidol pretreatment.
    Hitri A, Weiner WJ, Borison RL, Diamond BI, Nausieda PA, Klawans HL.
    Ann Neurol; 1978 Feb; 3(2):134-40. PubMed ID: 655662
    [Abstract] [Full Text] [Related]

  • 2. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW, Schwartz R, Friedhoff AJ.
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
    [Abstract] [Full Text] [Related]

  • 3. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH, Diamond BI.
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [Abstract] [Full Text] [Related]

  • 4. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR, Johnson KM.
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [Abstract] [Full Text] [Related]

  • 5. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY, Chai BL, Thompson PA, Yamamoto BK.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R, Marsden CA.
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [Abstract] [Full Text] [Related]

  • 7. Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
    Koller WC.
    J Clin Psychopharmacol; 1984 Dec; 4(6):343-5. PubMed ID: 6512004
    [Abstract] [Full Text] [Related]

  • 8. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P, Kerwin R, Rupniak NM, Murugaiah K, Hall MD, Fleminger S, Marsden CD.
    J Neural Transm Suppl; 1983 Dec; 18():205-12. PubMed ID: 6135741
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
    Ichikawa J, Meltzer HY.
    J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
    [Abstract] [Full Text] [Related]

  • 10. Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum.
    Wiedemann DJ, Garris PA, Near JA, Wightman RM.
    J Pharmacol Exp Ther; 1992 May; 261(2):574-9. PubMed ID: 1533666
    [Abstract] [Full Text] [Related]

  • 11. The pathophysiology of tardive dyskinesia.
    Klawans HL, Carvey P, Tanner CM, Goetz CG.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [Abstract] [Full Text] [Related]

  • 12. Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.
    Friedhoff AJ, Bonnet K, Tosengarten H.
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):411-23. PubMed ID: 847296
    [Abstract] [Full Text] [Related]

  • 13. Lithium interferes with reserpine-induced dopamine depletion.
    Reches A, Hassan MN, Jackson V, Fahn S.
    Ann Neurol; 1983 Jun; 13(6):671-3. PubMed ID: 6410976
    [Abstract] [Full Text] [Related]

  • 14. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM, Matvienko OA, Nurk AM.
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [Abstract] [Full Text] [Related]

  • 15. Does neuroleptic blocking of dopamine receptors continue after chronic treatment?
    Belmaker RH, Dasberg H, Ebstein RP.
    Prog Biochem Pharmacol; 1980 Oct; 16():109-18. PubMed ID: 6108567
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Striatal membrane 3H-dopamine binding in an animal model of tardive dyskinesia.
    Klawans HL, Hitri A.
    Psychopharmacol Bull; 1978 Oct; 14(4):72-6. PubMed ID: 704768
    [No Abstract] [Full Text] [Related]

  • 18. Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.
    Scalzo FM, Spear LP.
    Psychopharmacology (Berl); 1985 Oct; 85(3):271-6. PubMed ID: 3923514
    [Abstract] [Full Text] [Related]

  • 19. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
    Allen RM, Lane JD, Brauchi JT.
    Eur J Pharmacol; 1980 Jul 25; 65(2-3):313-5. PubMed ID: 7190503
    [Abstract] [Full Text] [Related]

  • 20. Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia.
    Hamid EH, Hyde TM, Baca SM, Egan MF.
    Brain Res; 1998 Jun 15; 796(1-2):291-5. PubMed ID: 9689480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.